-The Indian Express India may not be a testing hub for Big Pharma. But informed consent must be non-negotiable Figures released by the World Health Organisation, which show that 10 Indian subjects of clinical field trials die every week, have rekindled concerns that this country has become a testing hub for Big Pharma. Ironically, the same figures deflate this persistent fear, revealing that only 1.5 per cent of global trials have been...

The NAC lies defanged; the markets leap for joy at Manmohan’s & Co’s charge of a ‘new’ economy How swiftly things change. Just a month ago, the great Indian growth story was being written off. Now, the “new economy”, run by the PM-cum-FM, will sift through the rubble of under-seven per cent growth, find the hidden springs of recovery and throw in some reforms for good measure. A top taxman says...

-Tehelka Justice Sujata Manohar on how the Biotechnology Bill is fundamentally flawed IN THE last few years, regulatory systems across the board have been undergoing an overhaul to fit the needs of a new era. Likewise, new laws are being chalked out to meet new needs, and several are receiving flak owing to the loopholes and regressive grounds on which these have been drafted. The relatively more recent one to regulate modern...

By repeatedly decrying the CAG and trying to malign the person occupying that Constitutional office, the UPA government is weakening an important pillar of democracy and lowering its own credibility Admitting that there is a great deal of uncertainty and a perception of policy paralysis in the government these days, a senior Cabinet colleague of the prime minister recently observed that it was being created by the activities of (Comptroller and...

-The Economic Times Decks have been cleared for reintroduction of the Companies Bill, 2011, in the monsoon session. If the bill is passed after endorsing all the suggestions made by the Parliamentary Standing Committee on Finance, corporate social responsibility (CSR) would, for the first time in the world, become mandatory.  The report recommends that companies with net worth above Rs 500 crore, or an annual turnover of over Rs 1,000 crore, earmark...